Laboratorio 6, Departamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados-Instituto Politécnico Nacional, Delegación Tlalpan, Ciudad de México, México
Search for other papers by Jorge Alberto Tapia-Martínez in
Google Scholar
PubMed
Search for other papers by Margarita Franco-Colín in
Google Scholar
PubMed
Search for other papers by Vanessa Blas-Valdivia in
Google Scholar
PubMed
Search for other papers by Edgar Cano-Europa in
Google Scholar
PubMed
with type 2 diabetes mellitus (T2D) development ( 7 ), but until now neither in rats nor in humans, this hypothesis has been proved. In humans, some meta-analyses reveal an association between hypothyroidism, obesity, and dyslipidemia; however, it is
Search for other papers by Dominik Spira in
Google Scholar
PubMed
Search for other papers by Nikolaus Buchmann in
Google Scholar
PubMed
German Centre for Cardiovascular Research (DZHK), partner site Greifswald, Greifswald, Germany
Search for other papers by Marcus Dörr in
Google Scholar
PubMed
German Centre for Cardiovascular Research (DZHK), partner site Greifswald, Greifswald, Germany
Search for other papers by Marcello R P Markus in
Google Scholar
PubMed
Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany
Search for other papers by Matthias Nauck in
Google Scholar
PubMed
Search for other papers by Sabine Schipf in
Google Scholar
PubMed
Search for other papers by Joachim Spranger in
Google Scholar
PubMed
Charité – Universitätsmedizin Berlin, BCRT – Berlin Institute of Health Center for Regenerative Therapies, Berlin, Germany
Search for other papers by Ilja Demuth in
Google Scholar
PubMed
Search for other papers by Elisabeth Steinhagen-Thiessen in
Google Scholar
PubMed
Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
Search for other papers by Henry Völzke in
Google Scholar
PubMed
Search for other papers by Till Ittermann in
Google Scholar
PubMed
with low thyroid function and prediabetes seem to be more likely to progress to type 2 diabetes compared to those with prediabetes and thyroid hormone levels in the reference range ( 6 ). The effects of subclinical hypo- or hyperthyroidism on glucose
Search for other papers by Georgiana Sitoris in
Google Scholar
PubMed
Search for other papers by Flora Veltri in
Google Scholar
PubMed
Search for other papers by Malika Ichiche in
Google Scholar
PubMed
Search for other papers by Pierre Kleynen in
Google Scholar
PubMed
Search for other papers by Jean-Philippe Praet in
Google Scholar
PubMed
Search for other papers by Serge Rozenberg in
Google Scholar
PubMed
Search for other papers by Kris G Poppe in
Google Scholar
PubMed
Introduction Thyroid autoimmunity (TAI) and (subclinical) hypothyroidism (SCH) have been associated with adverse pregnancy outcomes, such as miscarriage, preterm birth, and gestational diabetes mellitus (GDM) ( 1 ). TAI and GDM have been
Search for other papers by Theodora Pappa in
Google Scholar
PubMed
Department of Endocrinology, Metabolism and Diabetes, Evgenideion Hospital, Athens University School of Medicine, Athens, Greece
Search for other papers by Maria Alevizaki in
Google Scholar
PubMed
Introduction Metformin is well established as a first-line pharmacotherapy for the management of diabetes mellitus (DM). This biguanide is an insulin sensitizer mainly in the liver, but also in the muscle, that activates AMP-activated protein
Search for other papers by John H. Lazarus in
Google Scholar
PubMed
): Oxford Textbook of Endocrinology and Diabetes, ed 2. Oxford, Oxford University Press, 2011, pp 552–557. 24 Rotondi M, Cappelli C, Pirali B, Pirola I, Magri F, Fonte R, Castellano M, Rosei EA, Chiovato L: The effect of pregnancy on subsequent
Search for other papers by Antonio C. Bianco in
Google Scholar
PubMed
Search for other papers by Sabina Casula in
Google Scholar
PubMed
increased BMI [ 53 ], and subsequently with type 2 diabetes mellitus [ 54 ]. A recent case-control study with 1,057 type 2 diabetes patients and 516 non-diabetic subjects indicated that the frequencies of D 2 Ala92Ala homozygosity were 16.4% (n = 173
Centre for Endocrine and Diabetes Sciences, Department of Medicine, Cardiff University School of Medicine, Cardiff, UK
Search for other papers by Peter Taylor in
Google Scholar
PubMed
Search for other papers by Sandip Bhatt in
Google Scholar
PubMed
Search for other papers by Ravi Gouni in
Google Scholar
PubMed
Search for other papers by Jonathan Quinlan in
Google Scholar
PubMed
Search for other papers by Tony Robinson in
Google Scholar
PubMed
of Prof. Colin Dayan (Centre for Endocrine and Diabetes Science, Cardiff University School of Medicine, Cardiff, UK) and Prof. Tony Weetman (Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, UK). References 1
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Marko Stojanović in
Google Scholar
PubMed
Neuroendocrine Department, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Sandra Pekić in
Google Scholar
PubMed
Neuroendocrine Department, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Mirjana Doknić in
Google Scholar
PubMed
Neuroendocrine Department, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Dragana Miljić in
Google Scholar
PubMed
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Slavica Ćirić in
Google Scholar
PubMed
Endocrine Surgery Department, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Aleksandar Diklić in
Google Scholar
PubMed
Institute of Pathology, Clinical Center of Serbia, Belgrade, Serbia
Search for other papers by Svetislav Tatić in
Google Scholar
PubMed
Search for other papers by Miloje Joksimović in
Google Scholar
PubMed
Institute of Pathology, Clinical Center of Serbia, Belgrade, Serbia
Search for other papers by Emilija Manojlović-Gačić in
Google Scholar
PubMed
Institute of Pathology, Clinical Center of Serbia, Belgrade, Serbia
Search for other papers by Milica Skender-Gazibara in
Google Scholar
PubMed
Neuroendocrine Department, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Vera Popović in
Google Scholar
PubMed
What Is Known about This Topic? • Sellar masses most commonly represent pituitary adenoma, and only rarely metastatic tumors, usually originating from breast or lung carcinoma. Accelerated growth of a sellar mass, rapid onset of diabetes
Search for other papers by Dulani Kottahachchi in
Google Scholar
PubMed
Department of Medicine, Monash University, Melbourne, VIC, Australia
Search for other papers by Duncan J. Topliss in
Google Scholar
PubMed
, Takahashi Y: The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and/or central diabetes insipidus and review of the literature. Eur J Endocrinol 2014;170:161-172. 10.1530/EJE-13-0642 24165017
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal
Search for other papers by João Sérgio Neves in
Google Scholar
PubMed
Department of Cardiology, Centro Hospitalar Gaia/Espinho, Vila Nova de Gaia, Portugal
Search for other papers by Ricardo Fontes-Carvalho in
Google Scholar
PubMed
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal
Search for other papers by Marta Borges-Canha in
Google Scholar
PubMed
Search for other papers by Ana Rita Leite in
Google Scholar
PubMed
EPIUnit – Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal
Search for other papers by Sandra Martins in
Google Scholar
PubMed
Search for other papers by Ana Oliveira in
Google Scholar
PubMed
Department of Biomedicine, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
EPIUnit – Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal
Search for other papers by João Tiago Guimarães in
Google Scholar
PubMed
Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Porto, Portugal
Search for other papers by Davide Carvalho in
Google Scholar
PubMed
Search for other papers by Adelino Leite-Moreira in
Google Scholar
PubMed
Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
Search for other papers by Ana Azevedo in
Google Scholar
PubMed
Introduction Cardiovascular disease is the leading cause of death worldwide. Traditional risk factors, including diabetes, dyslipidemia, and hypertension, contribute significantly to the development of cardiovascular disease [ 1 ]. Intensive